Cargando…
Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors
[Image: see text] Cholinesterases (ChE) are well-known drug targets for the treatment of Alzheimer’s disease (AD). In continuation of work to develop novel cholinesterase inhibitors, we utilized a structure-based scaffold repurposing approach and discovered six novel ChE inhibitors from our recently...
Autores principales: | Dighe, Satish N., Tippana, Mangapathiraju, van Akker, Suzannah, Collet, Trudi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726787/ https://www.ncbi.nlm.nih.gov/pubmed/33324805 http://dx.doi.org/10.1021/acsomega.0c03848 |
Ejemplares similares
-
Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities
por: Fitzgerald, Paul J., et al.
Publicado: (2021) -
Antibacterial Potential of Extracts and Phytoconstituents Isolated from Syncarpia hillii Leaves In Vitro
por: Perera, Muthukuttige M. N., et al.
Publicado: (2022) -
Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches
por: Hwang, Jayeong, et al.
Publicado: (2021) -
Structure-Based Search for New Inhibitors of Cholinesterases
por: Bajda, Marek, et al.
Publicado: (2013) -
Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing
por: Taylor, Lewis, et al.
Publicado: (2014)